Alfuzosin Hydrochloride
Product Images NDC 33261-994

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Alfuzosin Hydrochloride (NDC 33261-994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Alfuzosin Er 10 mg For Sun 1)

Chemical structure of Alfuzosin Hydrochloride showing its molecular framework, including methoxy groups, amino functionality, and heterocyclic components, with a hydrochloride salt indicated.*

FDA Label Image

Figure-1 (Alfuzosin Er 10 mg For Sun 2)

A line graph showing alfuzosin plasma concentration (ng/mL) over time (hours) comparing fed and fasted states. The fed condition shows higher plasma concentrations peaking around 10-12 hours, while the fasted condition shows lower concentrations with a plateau beginning around 4 hours.*

FDA Label Image

Figure-2 (Alfuzosin Er 10 mg For Sun 3)

A line graph showing the mean change over days of treatment (0, 28, 56, 84) comparing placebo and Alfuzosin hydrochloride extended-release tablets. The graph includes sample sizes (Placebo N=167, Alfuzosin hydrochloride N=170) and highlights a statistically significant difference with p<0.001 at day 84.*

FDA Label Image

Figure-3 (Alfuzosin Er 10 mg For Sun 4)

A line graph comparing the mean change over days of treatment between a placebo group and an Alfuzosin hydrochloride extended-release tablets group. The x-axis shows days of treatment (0, 28, 56, 84), and the y-axis shows mean change, with the Alfuzosin group showing a greater decrease over time compared to placebo.*

FDA Label Image

Figure-4 (Alfuzosin Er 10 mg For Sun 5)

A line graph showing mean change over days of treatment comparing placebo and Alfuzosin hydrochloride extended-release tablets, with measured points at 0, 28, 56, and 84 days. The graph indicates a greater decrease in mean change for Alfuzosin hydrochloride versus placebo over time, with statistical significance noted at day 84 (p < 0.01).*

FDA Label Image

Figure-5 (Alfuzosin Er 10 mg For Sun 6)

A line graph comparing the mean change over days of treatment for Placebo (N=167) and Alfuzosin Hydrochloride extended-release tablets (N=170). The y-axis represents mean change in mL/s, and the x-axis shows days of treatment at 0, 28, 56, and 84 days. The graph shows a significant increase for Alfuzosin Hydrochloride compared to Placebo, with a noted statistical significance (p < 0.001).*

FDA Label Image

Figure-6 (Alfuzosin Er 10 mg For Sun 7)

A line graph comparing mean change in mL/s over days of treatment (0, 14, 28, 56, 84) between placebo (N=147) and Alfuzosin hydrochloride extended-release tablets (N=136). The graph shows an increase over time with higher mean change values for Alfuzosin hydrochloride compared to placebo, with statistical significance indicated at day 84 (p < 0.05).*

FDA Label Image

Figure-7 (Alfuzosin Er 10 mg For Sun 8)

A line graph depicting the mean change in mL/s over days of treatment (0, 14, 28, 56, 84) for Alfuzosin hydrochloride extended-release tablets compared to placebo. The graph shows two lines with data points, one for placebo (n=150) and one for Alfuzosin hydrochloride extended-release tablets (n=151), with a note indicating no statistically significant difference (NS, p > 0.05).*

FDA Label Image

Image Label (Alfuzosin Er 10 mg For Sun 9)

Alfuzosin ER 10mg tablet bottle label by Aidarex Pharmaceuticals LLC. The label shows 30 extended-release tablets, with active ingredient Alfuzosin Hydrochloride 10mg. It includes NDC 33261-0994-30 and generic for Uroxatral, manufactured by Sun Pharmaceutical Ind. Ltd. India. The label contains medication instructions and identification codes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.